soc-neuro-onc.org
The Neuro-Oncology Family of Journals
The Neuro-Oncology family of journals continues to provide exceptional value to the field.
SNO’s flagship journal, Neuro-Oncology is committed to publishing the highest quality research to enhance the scientific understanding of CNS tumors. Published in partnership with the European Association of Neuro- Oncology, Neuro-Oncology Practice continues to perform well, and is an important educational resource for those on the frontlines of clinical care. Also published in partnership with EANO, Neuro-Oncology Advances is the premier Open Access title in the field and ensures that SNO is at the forefront of academic publishing. The Society for Neuro-Oncology is pleased to share that the most recent Journal Citation Reports™ provides that the Impact Factor for Neuro-Oncology , has risen to 13.029 (up from 12.30).
Given the relatively narrow editorial focus of Neuro- Oncology as a subspecialty publication, these are remarkable statistics, and the Society is grateful to Kenneth Aldape who served as Editor-in-Chief of Neuro-Oncology during the period that the new citation report covers.
Citation Impact – A Quality Metric
13.029
12.3
10.091 10.247
9.384
2017
2018
2019
2020
2021
New Editorial Leadership for Neuro-Oncology This year SNO announced the appointment of Susan Chang as the new Editor-in-Chief of Neuro-Oncology. Dr. Chang succeeds Dr. Kenneth Aldape. Dr. Chang is a Professor of Neurological Surgery at the University of California, San Francisco Weill Institute for Neurosciences, and co-leader of the Neuro-Oncology Program at the Helen Diller Family Comprehensive Cancer Center. No stranger to editorial leadership, she formerly served as the Founding Editor-in-Chief of Neuro-Oncology ’s sister title, Neuro-Oncology Practice . Her outstanding record of academic excellence, past service to the Society, and familiarity with the neuro-oncology publishing enterprise, makes her the ideal candidate to advance the educational mission of the journal. Commenting on her appointment, Dr. Chang said: “I am humbled and honored to be named to this role. I stand on the shoulders of giants – former Editors Drs. Darell Bigner, W.K. Alfred Yung, Patrick Wen, and Kenneth Aldape – and I am eager to build on their outstanding efforts to take the journal to new heights. I look forward to working with the leaders of ASNO, EANO and SNO, the Editorial Board, and all neuro-oncology stakeholders, as we build community, increase diversity, and generate data-driven education and innovation to our readers around the world.”
4 Society for Neuro-Oncology
Made with FlippingBook - Share PDF online